Concepts (106)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Urinary Tract Infections | 6 | 2025 | 327 | 2.100 |
Why?
|
| Soft Tissue Infections | 3 | 2023 | 89 | 1.510 |
Why?
|
| Mucocutaneous Lymph Node Syndrome | 2 | 2023 | 77 | 1.450 |
Why?
|
| Fever | 5 | 2023 | 306 | 1.250 |
Why?
|
| Urogenital Abnormalities | 3 | 2025 | 159 | 1.100 |
Why?
|
| Bacterial Infections | 2 | 2021 | 322 | 0.960 |
Why?
|
| Patient Readmission | 5 | 2019 | 429 | 0.910 |
Why?
|
| Hospitalists | 1 | 2026 | 51 | 0.900 |
Why?
|
| Staphylococcal Scalded Skin Syndrome | 2 | 2021 | 8 | 0.820 |
Why?
|
| Anti-Bacterial Agents | 7 | 2025 | 2545 | 0.790 |
Why?
|
| Treatment Failure | 2 | 2024 | 351 | 0.780 |
Why?
|
| Pediatrics | 2 | 2026 | 1243 | 0.710 |
Why?
|
| Evidence-Based Medicine | 2 | 2022 | 646 | 0.690 |
Why?
|
| Coinfection | 1 | 2023 | 187 | 0.680 |
Why?
|
| Bacteremia | 2 | 2024 | 425 | 0.660 |
Why?
|
| Hospitals, Pediatric | 4 | 2026 | 802 | 0.660 |
Why?
|
| Virus Diseases | 1 | 2023 | 284 | 0.650 |
Why?
|
| Vesico-Ureteral Reflux | 2 | 2024 | 79 | 0.640 |
Why?
|
| Clinical Clerkship | 1 | 2020 | 70 | 0.620 |
Why?
|
| Clinical Competence | 1 | 2026 | 1048 | 0.570 |
Why?
|
| Urinary Bladder | 1 | 2020 | 219 | 0.570 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2021 | 230 | 0.570 |
Why?
|
| Education, Medical, Undergraduate | 1 | 2020 | 170 | 0.550 |
Why?
|
| Fever of Unknown Origin | 1 | 2017 | 43 | 0.500 |
Why?
|
| Health Care Rationing | 1 | 2017 | 58 | 0.490 |
Why?
|
| Enterovirus | 1 | 2017 | 52 | 0.490 |
Why?
|
| Enterovirus Infections | 1 | 2017 | 48 | 0.480 |
Why?
|
| Biomedical Research | 1 | 2022 | 559 | 0.480 |
Why?
|
| Staphylococcal Infections | 1 | 2021 | 563 | 0.480 |
Why?
|
| Meningitis, Bacterial | 1 | 2017 | 98 | 0.470 |
Why?
|
| Students, Medical | 1 | 2020 | 341 | 0.470 |
Why?
|
| Ultrasonography | 1 | 2020 | 963 | 0.460 |
Why?
|
| Infant | 14 | 2025 | 13269 | 0.450 |
Why?
|
| Infant, Newborn | 12 | 2025 | 8493 | 0.450 |
Why?
|
| Caregivers | 2 | 2019 | 572 | 0.410 |
Why?
|
| Disease Management | 1 | 2017 | 559 | 0.380 |
Why?
|
| Guideline Adherence | 1 | 2015 | 390 | 0.380 |
Why?
|
| Cohort Studies | 5 | 2023 | 5069 | 0.370 |
Why?
|
| Medication Adherence | 1 | 2015 | 333 | 0.360 |
Why?
|
| Diagnostic Errors | 1 | 2015 | 345 | 0.350 |
Why?
|
| Humans | 24 | 2026 | 130372 | 0.320 |
Why?
|
| Retrospective Studies | 10 | 2025 | 17606 | 0.300 |
Why?
|
| Child | 11 | 2025 | 26160 | 0.300 |
Why?
|
| Practice Patterns, Physicians' | 2 | 2025 | 770 | 0.230 |
Why?
|
| Hematologic Tests | 2 | 2023 | 35 | 0.230 |
Why?
|
| Male | 12 | 2026 | 64517 | 0.220 |
Why?
|
| Female | 12 | 2026 | 70274 | 0.210 |
Why?
|
| Uncertainty | 1 | 2024 | 96 | 0.200 |
Why?
|
| Skin Diseases, Infectious | 1 | 2023 | 25 | 0.200 |
Why?
|
| Urinary Tract | 1 | 2024 | 53 | 0.200 |
Why?
|
| Prospective Studies | 2 | 2026 | 6421 | 0.190 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 2023 | 146 | 0.190 |
Why?
|
| Attitude of Health Personnel | 2 | 2026 | 700 | 0.180 |
Why?
|
| Hospitalization | 3 | 2025 | 1927 | 0.160 |
Why?
|
| Length of Stay | 3 | 2025 | 1392 | 0.160 |
Why?
|
| Aftercare | 2 | 2024 | 150 | 0.150 |
Why?
|
| Child, Preschool | 6 | 2025 | 14984 | 0.150 |
Why?
|
| Child, Hospitalized | 1 | 2020 | 78 | 0.150 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2026 | 906 | 0.150 |
Why?
|
| Sudden Infant Death | 1 | 2019 | 37 | 0.150 |
Why?
|
| Emergency Service, Hospital | 3 | 2025 | 1202 | 0.150 |
Why?
|
| Staphylococcal Skin Infections | 1 | 2019 | 37 | 0.140 |
Why?
|
| Blood Cell Count | 1 | 2018 | 64 | 0.140 |
Why?
|
| Blood Culture | 1 | 2018 | 35 | 0.140 |
Why?
|
| Blood Chemical Analysis | 1 | 2018 | 81 | 0.140 |
Why?
|
| Artificial Intelligence | 1 | 2023 | 346 | 0.140 |
Why?
|
| Research Design | 1 | 2022 | 717 | 0.140 |
Why?
|
| Learning | 1 | 2020 | 371 | 0.130 |
Why?
|
| Observational Studies as Topic | 1 | 2017 | 101 | 0.120 |
Why?
|
| Patient Discharge | 2 | 2024 | 508 | 0.120 |
Why?
|
| Urography | 1 | 2015 | 20 | 0.120 |
Why?
|
| Lymphadenitis | 1 | 2015 | 26 | 0.120 |
Why?
|
| Ultrasonography, Doppler, Color | 1 | 2015 | 57 | 0.120 |
Why?
|
| Failure to Thrive | 1 | 2015 | 87 | 0.110 |
Why?
|
| Health Care Costs | 1 | 2018 | 400 | 0.110 |
Why?
|
| Adult | 3 | 2026 | 31117 | 0.100 |
Why?
|
| Acute Disease | 1 | 2017 | 1151 | 0.100 |
Why?
|
| Polymerase Chain Reaction | 1 | 2017 | 1458 | 0.100 |
Why?
|
| Practice Guidelines as Topic | 2 | 2019 | 1291 | 0.090 |
Why?
|
| Risk Factors | 2 | 2023 | 10937 | 0.090 |
Why?
|
| Diagnosis, Differential | 1 | 2017 | 1889 | 0.090 |
Why?
|
| Communication | 1 | 2015 | 531 | 0.090 |
Why?
|
| Sensitivity and Specificity | 1 | 2015 | 2106 | 0.080 |
Why?
|
| Surveys and Questionnaires | 1 | 2020 | 4001 | 0.080 |
Why?
|
| Prevalence | 1 | 2017 | 2684 | 0.080 |
Why?
|
| Predictive Value of Tests | 1 | 2015 | 2297 | 0.080 |
Why?
|
| Disease Progression | 1 | 2015 | 2207 | 0.070 |
Why?
|
| Quality Improvement | 1 | 2014 | 698 | 0.070 |
Why?
|
| Adolescent | 4 | 2025 | 20747 | 0.070 |
Why?
|
| Cross-Sectional Studies | 1 | 2017 | 3800 | 0.070 |
Why?
|
| Time Factors | 1 | 2017 | 6186 | 0.060 |
Why?
|
| Equivalence Trials as Topic | 1 | 2024 | 21 | 0.050 |
Why?
|
| Multicenter Studies as Topic | 1 | 2024 | 299 | 0.050 |
Why?
|
| Administration, Oral | 1 | 2024 | 695 | 0.040 |
Why?
|
| Animals | 1 | 2022 | 33924 | 0.040 |
Why?
|
| Pneumonia | 1 | 2024 | 338 | 0.040 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2024 | 1257 | 0.040 |
Why?
|
| Blood Sedimentation | 1 | 2018 | 26 | 0.040 |
Why?
|
| Streptococcus pyogenes | 1 | 2018 | 84 | 0.030 |
Why?
|
| Tertiary Care Centers | 1 | 2018 | 248 | 0.030 |
Why?
|
| Streptococcal Infections | 1 | 2018 | 251 | 0.030 |
Why?
|
| C-Reactive Protein | 1 | 2018 | 444 | 0.030 |
Why?
|
| Qualitative Research | 1 | 2019 | 695 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2024 | 5185 | 0.030 |
Why?
|
| United States | 1 | 2025 | 11819 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2019 | 12855 | 0.010 |
Why?
|